Clinical Trials: Interstitial Cystitis

Birmingham : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Glendale : Clinical Trials of Arizona

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Escondido : Philip C. Bosch, MD

Efficacy Study of Adalimumab to Treat Interstitial Cystitis

Glendora : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Glendora : Citrus Valley Medical Research, Inc

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Long Beach : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

San Diego : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

View More »

Stanford : Stanford University Department of Urology

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Boulder : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Denver : Genitourinary Surgical Consultants

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Wheat Ridge : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Farmington : Women's Health Specialty Care

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

New Britain : Grove Hill Clinical Research

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Aventura : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Boynton Beach : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Bradenton : Manatee Medical Research Institute, LLC

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Palm Harbor : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Plantation : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

View More »

Wellington : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Atlanta : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Meridian : Idaho Urologic Center

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Centralia : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Evanston : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Jeffersonville : First Urology

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Shreveport : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Shreveport : Regional Urology LLC

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Burlington : Lahey Clinic Medical Center

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Watertown : Bay State Clinical Trials, Inc

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Grand Rapids : Female Pelvic Medicine & Urogynecology

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Royal Oak : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Royal Oak : William Beaumont Hospital

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Las Vegas : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Las Vegas : Sheldon Freedman, MD Ltd

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Marlton : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Albany : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

New Hyde Park : Arthur Smith Institute for Urology

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Rochester : University of Rochester, Department of Urology

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Raleigh : Wake Research Associates

Study of Moderate to Severe Bladder Pain (Interstitial Cystitis)

View More »

Winston Salem : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Winston-Salem : Wake Forest University Health Sciences Medical Center

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Cincinnati : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Cleveland : MetroHealth Medical Center

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Lima : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Oklahoma City : University of Oklahoma Health Science Center, Dept of Urology

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Tualatin : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Philadelphia : Pelvic and Sexual Health Institute

Sacral Neuromodulation in Patients With IC

Greer : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Myrtle Beach : Carolina Urologic Research Center

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Nashville : Vanderbilt University Medical Center

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Corsicana : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Fort Worth : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Ogden : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Mountlake Terrace : Integrity Medical Research, LLC

A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension

View More »

Mountlake Terrace : MediciNova Investigational Site

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Mountlake Terrace : Integrity Medical Research

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Brampton : Bramalea Medical Centre

Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome

Kingston : Centre for Applied Urologic Research/Kingston General Hospital

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Oakville : The Fe/Male Health Centres

Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome

Victoria : Pacific Urological Research

Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS in Women With Interstitial Cystitis, Followed by Open-label Extension

Prague :

OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)

Krakow :

OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)

Sheffield : Royal Hallamshire Hospital

OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)